These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35019252)

  • 21. The 57th amino acid conveys the differential subcellular localization of human immunodeficiency virus-1 Tat derived from subtype B and C.
    Zhao X; Qian L; Qi D; Zhou D; Shen W; Liu Y; Liu C; Kong X
    Virus Genes; 2016 Apr; 52(2):179-88. PubMed ID: 26832332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Integrase Sequences from HIV-1 Subtypes A6/A1 on the
    Jeffrey JL; St Clair M; Wang P; Wang C; Li Z; Beloor J; Talarico C; Fridell R; Krystal M; White CT; Griffith S; D'Amico R; Smith K; Van Eygen V; Vingerhoets J; Vandermeulen K; Spreen W; van Lunzen J
    Antimicrob Agents Chemother; 2022 Mar; 66(3):e0170221. PubMed ID: 34978890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.
    Desfosses Y; Solis M; Sun Q; Grandvaux N; Van Lint C; Burny A; Gatignol A; Wainberg MA; Lin R; Hiscott J
    J Virol; 2005 Jul; 79(14):9180-91. PubMed ID: 15994812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human immunodeficiency virus type 1 subtype C exhibits higher transactivation activity of Tat than subtypes B and E.
    Kurosu T; Mukai T; Komoto S; Ibrahim MS; Li YG; Kobayashi T; Tsuji S; Ikuta K
    Microbiol Immunol; 2002; 46(11):787-99. PubMed ID: 12516777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stability of HIV-1 subtype B and C Tat is associated with variation in the carboxyl-terminal region.
    Zhao X; Qian L; Zhou D; Qi D; Liu C; Kong X
    Virol Sin; 2016 Jun; 31(3):199-206. PubMed ID: 27007880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleotide and amino acid polymorphisms at drug resistance sites in non-B-subtype variants of human immunodeficiency virus type 1.
    Turner D; Brenner B; Moisi D; Detorio M; Cesaire R; Kurimura T; Mori H; Essex M; Maayan S; Wainberg MA
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2993-8. PubMed ID: 15273111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Highly prevalent Russian HIV-1 V3-loop sequence variants are susceptible to maraviroc.
    Lewis ME; Jubb B; Simpson P; Lopatukhin A; Kireev D; Bobkova M; Craig C; van der Ryst E; Westby M; Butler SL
    Antivir Chem Chemother; 2021; 29():20402066211025156. PubMed ID: 34160290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants.
    de Arellano ER; Alcamí J; López M; Soriano V; Holguín A
    Antiviral Res; 2010 Nov; 88(2):152-9. PubMed ID: 20713090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigating the distribution of HIV-1 Tat lengths present in the Drexel Medicine CARES cohort.
    Link RW; Mele AR; Antell GC; Pirrone V; Zhong W; Kercher K; Passic S; Szep Z; Malone K; Jacobson JM; Dampier W; Wigdahl B; Nonnemacher MR
    Virus Res; 2019 Oct; 272():197727. PubMed ID: 31437485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization.
    Ramakrishna L; Anand KK; Mohankumar KM; Ranga U
    J Virol; 2004 Sep; 78(17):9174-89. PubMed ID: 15308713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator.
    Roof P; Ricci M; Genin P; Montano MA; Essex M; Wainberg MA; Gatignol A; Hiscott J
    Virology; 2002 Apr; 296(1):77-83. PubMed ID: 12036319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis.
    Kuppuswamy M; Subramanian T; Srinivasan A; Chinnadurai G
    Nucleic Acids Res; 1989 May; 17(9):3551-61. PubMed ID: 2542902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transactivation and signaling functions of Tat are not correlated: biological and immunological characterization of HIV-1 subtype-C Tat protein.
    Siddappa NB; Venkatramanan M; Venkatesh P; Janki MV; Jayasuryan N; Desai A; Ravi V; Ranga U
    Retrovirology; 2006 Aug; 3():53. PubMed ID: 16916472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTR.
    Liu Y; Nonnemacher MR; Stauff DL; Li L; Banerjee A; Irish B; Kilareski E; Rajagopalan N; Suchitra JB; Khan ZK; Ranga U; Wigdahl B
    Biomed Pharmacother; 2010 Dec; 64(10):672-80. PubMed ID: 20970301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic variation and function of the HIV-1 Tat protein.
    Spector C; Mele AR; Wigdahl B; Nonnemacher MR
    Med Microbiol Immunol; 2019 Apr; 208(2):131-169. PubMed ID: 30834965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of lentivirus tat functional domains through generation of equine infectious anemia virus/human immunodeficiency virus type 1 tat gene chimeras.
    Carroll R; Martarano L; Derse D
    J Virol; 1991 Jul; 65(7):3460-7. PubMed ID: 1645777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study on the relationship between the polymorphisms and secondary structure of tat exon-1 gene and HIV/ AIDS progress in subtype B' and B'/C].
    Han XX; Dai D; Zhang Y; Zhang M; Zhang ZN; Diao YY; Geng WQ; Shang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Nov; 27(11):968-72. PubMed ID: 17402200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterization of tat gene and long terminal repeat region of human immunodeficiency virus type-1 detected among the injecting drug users (IDUs) of Manipur, India: identification of BC recombinants.
    Mullick R; Sengupta S; Sarkar K; Chakrabarti S
    Virus Res; 2010 Feb; 147(2):195-201. PubMed ID: 19896991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
    Murphy KM; Sweet MJ; Ross IL; Hume DA
    J Virol; 1993 Dec; 67(12):6956-64. PubMed ID: 8230418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine.
    Ranga U; Shankarappa R; Siddappa NB; Ramakrishna L; Nagendran R; Mahalingam M; Mahadevan A; Jayasuryan N; Satishchandra P; Shankar SK; Prasad VR
    J Virol; 2004 Mar; 78(5):2586-90. PubMed ID: 14963162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.